[1]戴媛,吴文君.T2DM骨骼肌病变的研究进展[J].国际内分泌代谢杂志,2021,41(04):352-355.[doi:10.3760/cma.j.cn121383-20200622-06061]
 Dai yuan,Wu Wenjun..Research progress on the type 2 diabetic myopathy[J].International Journal of Endocrinology and Metabolism,2021,41(04):352-355.[doi:10.3760/cma.j.cn121383-20200622-06061]
点击复制

T2DM骨骼肌病变的研究进展()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年04期
页码:
352-355
栏目:
综述
出版日期:
2021-07-20

文章信息/Info

Title:
Research progress on the type 2 diabetic myopathy
作者:
戴媛吴文君
南京医科大学附属无锡人民医院内分泌科 214023
Author(s):
Dai yuan Wu Wenjun.
Department of Endocrinology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China
关键词:
糖尿病骨骼肌病变 2型糖尿病 骨骼肌 发病机制 评估方法 治疗
Keywords:
Diabetic myopathy Type 2 diabetes mellitus Skeletal muscle Pathogenesis Assessment method Treatment
DOI:
10.3760/cma.j.cn121383-20200622-06061
摘要:
糖尿病骨骼肌病变是临床上易被忽视的一种糖尿病并发症。早期识别和预防糖尿病骨骼肌病变对于糖尿病患者的病情改善和预后至关重要。通过对2型糖尿病骨骼肌病变的概念、发病机制、评估方法以及治疗进展进行综述,希望引起临床医生对此种并发症的重视,提高其诊治水平,改善糖尿病患者的生活质量和预后。
Abstract:
Diabetic myopathy is an easily overlooked clinical diabetic complication. Early recognition and prevention of diabetic myopathy is very important for patients' improvement and prognosis. The definition, pathogenesis, assessment method, and progress of treatment related to the type 2 diabetic myopathy are reviewed, inorder to arouse clinical physicians' attention to this disease and improve their level of diagnosis and treatment resulting in patients' better prognosis and life.

参考文献/References:

[1] 何清华,孙明晓,岳燕芬,等.北京地区中老年2型糖尿病患者肌少症患病率研究及影响因素分析[J].中华糖尿病杂志,2019,11(5):328-33.DOI:10.3760/cma.j.issn.1674-5809.2019.05.004.
[2] Yong TY,Khow KSF.Diabetic muscle infarction in end-stage renal disease:a scoping review on epidemiology,diagnosis and treatment[J].World J Nephrol,2018,7(2):58-64.DOI:10.5527/wjn.v7.i2.58.
[3] Wang T,Feng X,Zhou J,et al.Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly[J].Sci Rep,2016,6:38937.DOI:10.1038/srep38937.
[4] Akeroyd JM,SuarezZ EA,Bartali B,et al.Differences in skeletal and non-skeletal factors in a diverse sample of men with and without type 2 diabetes mellitus[J].J Diabetes Complications,2014,28(5):679-683.DOI:10.1016/j.jdiacomp.2014.05.007.
[5] Sugimoto K,Tabara Y,Ikegami H,et al.Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass:The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus[J].J Diabetes Investig,2019,10(6):1471-1479.DOI:10.1111/jdi.13070.
[6] Katoh M,Isozaki K.Reliability of isometric knee extension muscle strength measurements of healthy elderly subjects made with a hand-held dynamometer and a belt[J].J Phys Ther Sci,2014,26(12):1855-1859.DOI:10.1589/jpts.26.1855.
[7] Nyholm B,Qu Z,Kaal A,et al.Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM[J].Diabetes,1997,46(11):1822-1828.DOI:10.2337/diab.46.11.1822.
[8] Frisbee JC,Lewis MT,Kasper JD,et al.Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue[J].J Appl Physiol(1985),2019,126(3):626-637.DOI:10.1152/japplphysiol.00751.2018.
[9] O'neill BT,Bhardwaj G,Penniman CM,et al.FoxO transcription factors are critical regulators of diabetes-related muscle atrophy[J].Diabetes,2019,68(3):556-570.DOI:10.2337/db18-0416.
[10] Abdulla H,Smith K,Atherton PJ,et al.Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown:a systematic review and meta-analysis[J].Diabetologia,2016,59(1),44-55.DOI:10.1007/s00125-015-3751-0.
[11] Andreassen CS,Jensen JM,Jakobsen J,et al.Striated muscle fiber size,composition,and capillary density in diabetes in relation to neuropathy and muscle strength[J].J Diabetes,2014,6(5):462-471.DOI.10.1111/1753-0407.12124.
[12] 孙洁,杨兵全,孙子林. 自噬与糖尿病骨骼肌病变[J].国际内分泌代谢杂志,2014,34(3):194-196.DOI:10.3760/cma.j.issn.1673-4157.2014.03.014.
[13] Sala D,Ivanova S,Plana N,et al.Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes[J].J Clin Invest,2014,124(5):1914-1927.DOI:10.1172/JCI72327.
[14] Møller AB,Kampmann U,Hedegaard J,et al.Altered gene expression and repressed markers of autophagy in skeletal muscle of insulin resistant patients with type 2 diabetes[J].Sci Rep,2017,7:43775.DOI:10.1038/srep43775.
[15] Guan Y,Cui ZJ,Sun B,et al.Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway[J].Int J Mol Med,2016,37(5):1229-1238.DOI:10.3892/ijmm.2016.2549.
[16] Scicchitano BM,Pelosi L,Sica G,et al.The physiopathologic role of oxidative stress in skeletal muscle[J].Mech Ageing Dev,2018,170:37-44.DOI:10.1016/j.mad.2017.08.009.
[17] Perandini LA,Chimin P,Lutkemeyer DDS,et al.Chronic inflammation in skeletal muscle impairs satellite cells function during regeneration:can physical exercise restore the satellite cell niche? [J].FEBS J,2018,285(11):1973-1984.DOI:10.1111/febs.14417.
[18] Lee DE,Brown JL,Rosa ME,et al.MicroRNA-16 is downregulated during insulin resistance and controls skeletal muscle protein accretion[J].J Cell Biochem,2016,117(8):1775-1787.DOI:10.1002/jcb.25476.
[19] Davy BM,Winett RA,Savla J,et al.Resist diabetes:a randomized clinical trial for resistance training maintenance in adults with prediabetes[J].PLoS One,2017,12(2):e0172610.DOI:10.1371/journal.pone.0172610.
[20] Lee J,Kim D,Kim C.Resistance training for glycemic control,muscular strength,and lean body mass in old type 2 diabetic patients:a meta-analysis[J].Diabetes Ther,2017,8(3):459-473.DOI:10.1007/s13300-017-0258-3.
[21] Massart J,Sjögren RJO,Lundell LS,et al.Altered miR-29 expression in type 2 diabetes influences glucose and lipid metabolism in skeletal muscle[J].Diabetes,2017,66(7):1807-1818.DOI:10.2337/db17-0141.
[22] Martins CEC,Lima VBS,Schoenfeld BJ,et al.Effects of leucine supplementation and resistance training on myopathy of diabetic rats[J].Physiol Rep,2017,5(10):e13273.DOI:10.14814/phy2.13273.
[23] Magnussen LV,Hvid LG,Hermann AP,et al.Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial[J].Andrology,2017,5(5):946-953.DOI:10.1111/andr.12396.
[24] Reddy SS,Shruthi K,Joy D,et al.4-PBA prevents diabetic muscle atrophy in rats by modulating ER stress response and ubiquitin-proteasome system[J].Chem Biol Interact,2019,306:70-77.DOI:10.1016/j.cbi.2019.04.009.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
 Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(04):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
 Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
 Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
 Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(04):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
 Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
 Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(04):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
 Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
 Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
 Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
 Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81500630); 无锡市卫生健康委中青年拔尖人才资助计划(BJ2020005)
通信作者:吴文君,Email:wuwenjung@163.com
更新日期/Last Update: 1900-01-01